Getting an ADHD diagnosis used to mean a months-long wait for a specialist, a battery of in-office neuropsychological tests costing $1,000 to $3,000, and weeks of uncertainty. Telehealth has compressed that timeline dramatically, with some platforms offering assessments in under a week and treatment starting shortly after. But finding the best telehealth for ADHD requires understanding which platforms are legitimate, how prescribing rules have changed under evolving DEA regulations, and what quality treatment actually looks like in a virtual setting. An estimated 8.7 million adults in the U.S. have ADHD according to the National Institute of Mental Health, and the majority were diagnosed in adulthood, often after years of struggling without understanding why. For background on how telehealth works across conditions, start with our comprehensive telehealth guide.
How ADHD Telehealth Works
ADHD telehealth typically involves three phases: assessment, diagnosis, and ongoing treatment. Understanding each phase helps you evaluate whether a platform’s approach is thorough enough to produce an accurate diagnosis.
Assessment: A licensed clinician (usually a psychiatrist, psychiatric nurse practitioner, or psychologist) conducts a comprehensive video interview lasting 45 to 90 minutes. They review standardized symptom questionnaires, such as the Adult ADHD Self-Report Scale (ASRS v1.1) or the Conners Adult ADHD Rating Scale. The interview explores your symptom history across different settings (work, home, relationships), childhood symptoms (ADHD is a neurodevelopmental condition that begins in childhood, even if not diagnosed until adulthood), and screens for conditions that mimic or co-occur with ADHD, including anxiety, depression, sleep disorders, and thyroid dysfunction.
Diagnosis: If the provider determines that you meet the DSM-5 criteria for ADHD — including at least six symptoms of inattention and/or hyperactivity-impulsivity present before age 12, with evidence of impairment in two or more settings — they’ll make a formal diagnosis. Not everyone who seeks an evaluation has ADHD; a quality provider will rule out other explanations for your symptoms before diagnosing.
Treatment: Treatment options typically include stimulant medications (methylphenidate, amphetamine-based medications), non-stimulant medications (atomoxetine, guanfacine, viloxazine), behavioral strategies, and ADHD coaching. Many platforms also offer therapy alongside medication management. Ongoing treatment involves monthly or bimonthly follow-up visits to assess medication effectiveness, adjust dosages, and monitor side effects. These follow-ups are well-suited to telehealth, as they involve conversation rather than physical examination.
Top Telehealth Platforms for ADHD
Done
Done is a dedicated ADHD telehealth platform offering evaluation, diagnosis, and medication management. Initial assessments cost approximately $199, with monthly follow-ups at $79 to $99 per month. Done accepts some insurance plans, which can reduce costs substantially — with insurance, you may only owe your plan’s specialist copay.
The platform connects you with psychiatric nurse practitioners and psychiatrists who focus exclusively on ADHD. Initial appointments are typically available within 3 to 7 days, significantly faster than the 2 to 4 month wait common for in-person ADHD evaluations. Done’s assessments include clinical interviews and standardized rating scales, meeting the diagnostic standard recommended by the American Psychiatric Association.
Done has adjusted its prescribing protocols in response to evolving DEA telemedicine rules. Patients prescribed Schedule II stimulants may need to complete an in-person evaluation within the first six months of treatment. Done provides guidance on how to fulfill this requirement, though the logistics fall primarily on the patient.
Cerebral
Cerebral offers ADHD treatment as part of its broader mental health platform, providing both medication management and therapy on a single platform. Medication management plans start at roughly $85 per month, while combined therapy and medication plans cost $259 to $325 per month. Cerebral accepts several insurance plans and actively verifies coverage during signup.
Cerebral underwent significant restructuring of its controlled substance prescribing practices in 2023 and 2024 following regulatory scrutiny from the DEA and critical media coverage. The platform now follows more conservative prescribing protocols, often starting with non-stimulant medications (atomoxetine, guanfacine, viloxazine) or non-medication approaches before considering stimulants. For patients whose clinical presentation clearly indicates stimulant treatment, Cerebral prescribers can still prescribe them, but the evaluation process is more thorough than in earlier iterations of the platform.
For patients who need comprehensive care (therapy plus medication), Cerebral’s integrated model is a genuine strength. Having your therapist and prescriber on the same platform facilitates communication about treatment response and allows for coordinated care planning.
ADHD Online
ADHD Online distinguishes itself by offering a comprehensive diagnostic assessment that includes the TOVA (Test of Variables of Attention), a computerized continuous performance test that measures attention, impulsivity, and processing speed. The assessment costs approximately $199 to $249 and is reviewed by a licensed psychologist who provides a detailed written report.
The TOVA adds a layer of objective data to the clinical interview that most other platforms don’t include. While the TOVA alone cannot diagnose ADHD (no single test can), it provides supporting evidence that strengthens diagnostic confidence. The detailed report is also valuable if you need documentation for workplace accommodations, academic support, or insurance appeals.
After diagnosis, ADHD Online offers medication management through its prescriber network at roughly $79 to $99 per month. The platform also provides coaching and educational resources for building organizational systems, time management skills, and coping strategies. The combination of rigorous assessment and ongoing treatment makes ADHD Online one of the more clinically thorough options available.
Ahead (formerly Klarity)
Ahead offers streamlined ADHD evaluations and medication management with initial visits starting at $149 to $199 and monthly follow-ups at $79 to $99. The platform accepts some insurance and emphasizes quick scheduling, with initial appointments often available within days rather than weeks.
Ahead’s model is focused primarily on medication management. If you also want therapy, ADHD coaching, or comprehensive psychological testing, you’ll need to supplement with another service. This makes Ahead a good fit for patients who have already been diagnosed (perhaps years ago during childhood) and primarily need a prescriber to manage their medication. Patients seeking a first-time diagnosis may benefit from a platform with a more thorough evaluation process.
Insurance-Based Options
Major insurers including UnitedHealthcare, Aetna, and Cigna cover psychiatry and ADHD treatment through their telehealth platforms. Copays typically run $20 to $75 per session, which can make ongoing treatment significantly cheaper than dedicated ADHD platforms if your plan has favorable behavioral health benefits.
The trade-off is longer wait times for appointments (often 2 to 6 weeks for an initial psychiatric evaluation through insurance-based telehealth) and fewer providers who specialize specifically in adult ADHD. Many insurance-based psychiatrists are generalists who treat the full spectrum of psychiatric conditions, whereas dedicated ADHD platforms have providers who focus primarily or exclusively on ADHD.
The DEA Factor: Stimulant Prescribing Rules
Any discussion of ADHD telehealth must address the regulatory landscape. Schedule II stimulants (Adderall, Ritalin, Vyvanse, Concerta, Focalin) are the most commonly prescribed ADHD medications and among the most tightly regulated substances in the U.S. pharmacopoeia.
Under current DEA rules, telehealth providers can prescribe an initial limited supply of stimulants (typically 30 days) via telehealth, but patients generally must complete an in-person evaluation within a defined period (often 180 days) to continue receiving prescriptions. The specifics of these requirements have evolved through multiple regulatory cycles and continue to be refined.
Non-stimulant medications like atomoxetine (Strattera), guanfacine (Intuniv), viloxazine (Qelbree), and clonidine (Kapvay) are not subject to these restrictions and can be prescribed freely through telehealth without an in-person visit. Some patients and providers opt to start with non-stimulant options both for clinical reasons (fewer side effects, no abuse potential) and to avoid regulatory complications. While stimulants are generally more effective for core ADHD symptoms, non-stimulants work well for many patients, particularly those with co-occurring anxiety.
It’s worth noting that the DEA’s concern isn’t that telehealth ADHD treatment is inherently problematic. The concern is about the potential for inadequate evaluations leading to inappropriate prescribing. Platforms that conduct thorough assessments and follow evidence-based prescribing practices are well-positioned to continue operating within the regulatory framework.
Cost Comparison
ADHD treatment costs vary significantly by platform and insurance status. Here’s a comprehensive summary of typical costs:
- Initial evaluation (dedicated platforms, cash pay): $149 to $249
- Monthly medication management (dedicated platforms): $79 to $99/month
- Comprehensive platforms with therapy: $259 to $349/month for combined medication and therapy
- Insurance-based telehealth: $20 to $75 per session (typically monthly visits, plus the initial evaluation copay)
- Medication costs with insurance: Generic stimulants $10 to $40/month; brand-name $30 to $300/month
- Medication costs without insurance: Generic Adderall $30 to $60/month; generic methylphenidate $20 to $50/month; brand-name Vyvanse $300 to $400/month (manufacturer copay cards may reduce this)
- Non-stimulant medication costs: Generic atomoxetine $15 to $50/month; generic guanfacine $10 to $30/month
For patients on high-deductible plans who haven’t met their deductible, cash-pay platforms may be cheaper than using insurance for the provider visits. However, insurance pharmacy benefits typically provide better medication pricing than cash pay, especially for brand-name medications. The math depends on your specific plan, deductible status, and medication. See our deductible vs. out-of-pocket maximum guide for help with this calculation.
Red Flags to Watch For
The rapid growth of ADHD telehealth has attracted both legitimate providers and questionable operators. The difference matters — a poor evaluation can lead to misdiagnosis (either missing ADHD or incorrectly diagnosing it), inappropriate treatment, and regulatory problems that could interrupt your care. Be cautious of platforms that:
- Guarantee a diagnosis before your evaluation (a legitimate provider cannot know the outcome in advance)
- Promise stimulant prescriptions upfront or use stimulant access as a marketing hook
- Don’t conduct thorough assessments, relying on a brief questionnaire and a 10-minute video chat
- Don’t screen for co-occurring conditions (anxiety, depression, sleep disorders, substance use) that affect treatment decisions
- Charge excessively for services that should be straightforward, or lock you into long-term contracts
- Have numerous complaints about difficulty canceling subscriptions or getting refunds
A legitimate ADHD evaluation should involve a detailed clinical interview lasting at least 30 to 45 minutes, standardized symptom rating scales, review of symptom history across settings (work, home, relationships), exploration of childhood symptoms, screening for co-occurring conditions, and a clear explanation of treatment options including non-medication approaches.
Frequently Asked Questions
Can a telehealth doctor diagnose ADHD?
Yes. Licensed psychiatrists, psychologists, and psychiatric nurse practitioners can diagnose ADHD through telehealth using clinical interviews and validated assessment tools. The American Psychiatric Association recognizes telehealth as an appropriate modality for ADHD evaluation. The key factor is the thoroughness of the evaluation, not whether it happens on a screen or in an office.
Can I get Adderall through telehealth?
Telehealth providers can prescribe Adderall and other stimulant medications, but current DEA rules may require an in-person visit within a specified timeframe to continue the prescription beyond an initial supply. Non-stimulant alternatives (atomoxetine, guanfacine, viloxazine) can be prescribed without this requirement. Your provider will explain the specific rules that apply to your situation and help you plan accordingly.
How long does an online ADHD assessment take?
Most telehealth ADHD evaluations take 45 to 90 minutes, including the clinical interview and review of symptom questionnaires. Some platforms like ADHD Online include computerized testing (TOVA) that adds 15 to 20 minutes. You’ll typically receive a diagnosis and treatment recommendation during or shortly after the evaluation session.
Is online ADHD treatment as effective as in-person?
Research published in the Journal of Clinical Psychiatry suggests that telehealth ADHD treatment produces comparable outcomes to in-person care for medication management. ADHD follow-up visits are primarily conversational (discussing symptom control, side effects, and dosage adjustments), making them well-suited to telehealth delivery.
What if I’ve been diagnosed with ADHD before but need a new provider?
If you have a prior diagnosis and existing medical records, most telehealth platforms can establish care more quickly. Bring your previous diagnosis documentation, medication history, and any relevant treatment records to your initial appointment. The new provider will review your history and may be able to continue your existing treatment plan after a shorter evaluation than a first-time assessment requires.
What to Do Next
If you suspect you have ADHD, start by checking whether your insurance covers telehealth psychiatric evaluations, as this is typically the cheapest option for ongoing treatment even if the wait is longer for an initial appointment. If cost or wait times are barriers, dedicated ADHD platforms like Done or ADHD Online can get you evaluated within a week. Be prepared for the possibility that treatment may involve both medication and behavioral strategies, and that stimulant prescriptions may require an eventual in-person visit under current regulations.
Getting assessed is the critical first step. Untreated ADHD affects career performance, relationships, financial management, and quality of life in profound ways. Adults who receive an accurate diagnosis and appropriate treatment consistently report significant improvements across all of these domains. Effective treatment is widely available through virtual care, and the process of getting started is far simpler than it was even five years ago.